US 12,421,294 B2
Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection
Michael C. Jensen, Duarte, CA (US)
Assigned to City of Hope, Duarte, CA (US)
Filed by City of Hope, Duarte, CA (US)
Filed on Oct. 22, 2021, as Appl. No. 17/507,996.
Application 15/431,248 is a division of application No. 14/340,512, filed on Jul. 24, 2014, granted, now 9,580,685, issued on Feb. 28, 2017.
Application 14/340,512 is a division of application No. 13/463,247, filed on May 3, 2012, granted, now 8,802,374, issued on Aug. 12, 2014.
Application 17/507,996 is a continuation of application No. 16/160,944, filed on Oct. 15, 2018, granted, now 11,155,783.
Application 16/160,944 is a continuation of application No. 15/431,248, filed on Feb. 13, 2017, granted, now 10,100,281, issued on Oct. 16, 2018.
Application 13/463,247 is a continuation of application No. PCT/US2010/055329, filed on Nov. 3, 2010.
Claims priority of provisional application 61/257,567, filed on Nov. 3, 2009.
Prior Publication US 2022/0041986 A1, Feb. 10, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 14/71 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/34 (2025.01); A61K 40/42 (2025.01); A61K 40/46 (2025.01); C12N 5/0783 (2010.01); C12N 9/12 (2006.01)